Vascular cell adhesion molecule-1 (VCAM-1) and leukocyte activation in pre-eclampsia and eclampsia

Objective: To evaluate the levels of VCAM-1 in pre-eclampsia/eclampsia as a possible marker of leukocyte activation and endothelial damage. Methods: W e performed a case-control study on 25 healthy pregnant women and 35 patien ts diagnosed as pre-eclampsia or eclampsia which were randomly selected. Pe ripheral venous blood samples were obtained and serum levels of VCAM-1 were measured by enzyme-linked immunoassay (ELISA). Results: In pre-eclampsia/e clampsia, VCAM-1 levels were higher than in normal pregnancy. Serum concent rations of VCAM-1 were significantly higher in severe pre-eclampsia and ecl ampsia compared to mild pre-eclampsia or healthy controls. ROC analysis det ected that VCAM-1 greater than or equal to 450 ng/ml had a sensitivity of 0 .79 and a specificity of 0.90 in detecting severe pre-eclampsia and eclamps ia. Conclusion: This is the first study to correlate VCAM-1 levels with sev erity of disease in pre-eclampsia. Our findings indicate that increasing le vels of soluble VCAM-1 are present in the circulation of patients with seve re pre-eclampsia/eclampsia compared to mild pre-eclampsia or healthy pregna nt women. Elevated VCAM-1 levels may represent a possible mechanism by whic h endothelial cells attract leukocytes and cause endothelial cell damage. ( C) 1998 International Federation of Gynecology and Obstetrics.